Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19
1 other identifier
observational
250
1 country
1
Brief Summary
This study aims to explore whether quarantine measures, social distancing and hospital containment policies among women giving birth during the COVID-19 pandemic enhanced psycho-emotional distress in the immediate postpartum period. The investigators tested for depression using the Edinburgh Postnatal Depression Scale (EPDS) in the first 6 postpartum months, and then used the Fear of COVID-19 Scale, measuring also the adherence and practices of breastfeeding according to WHO.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
February 2, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedOctober 2, 2023
September 1, 2023
5 months
February 2, 2021
September 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Post-Partum Depression Frequency
To explore the frequency of post-partum depression in women who gave birth during the COVID-19 pandemic
Baseline
Breast Feeding Adherence and behavior.
To explore the breastfeeding behavior of women who gave birth during the COVID-19 pandemic. The investigators asked the patients about the frequency of breastfeeding, the duration in months of how long the mothers breastfed in a previous child, if the participants have breastfed before, and whether the participants exclusively breastfed or complemented the nutrition with formula.
Baseline
Fear of Covid-19 severity
The Fear of Covid-19 Scale (FCV-19S) is a questionnaire that evaluates fear of the global pandemic caused by the SARS-CoV-2. The FVC-19S consists of seven items, such as "It makes me uncomfortable to think about coronavirus-19," "I am afraid of losing my life because of coronavirus-19," and "When watching news and stories about coronavirus-19 on social media, I become nervous or anxious," each with a five-point Likert scale of options. The participant is instructed to choose the option that best represents their perception about the statement presented. The maximum possible total is 35 points. The scale's authors indicate that the higher the score is, the higher is the level of the participants' fear of COVID-19.
Baseline
Interventions
The Edinburgh Postnatal Depression Scale is a self-administered questionnaire made up of 10 items scored using a four-point Likert scale (0-3) designed to screen for symptoms of postpartum depression. Postpartum depression represents the end of a continuum of severity of symptoms. The present study used a cutoff point for depressive symptomatology risk of higher than 12.
This will be addressed according to the breastfeeding initiation practices according to the WHO.
The Fear of Covid-19 Scale is a questionnaire that evaluates fear of the global pandemic caused by the SARS-CoV-2. It consists of seven items, each with a five-point Likert scale of options. The participant is instructed to choose the option that best represents their perception about the statement presented. The maximum possible total is 35 points. The scale's authors indicate that the higher the score is, the higher is the level of the participants' fear of COVID-19.
Eligibility Criteria
Women who delivered singletons at term in the last 6 months during the COVID-19 pandemic.
You may qualify if:
- Women aged ≥18 years
- Women who delivered singletons at term in the last 6 months during the COVID-19 pandemic
You may not qualify if:
- Women who delivered two or more products
- Women who delivered singletons at term past the last 6 months during the COVID-19 pandemic
- Women who delivered singletons pre or post-term in the last 6 months during the COVID-19 pandemic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Mexicano del Seguro Social
Guadalajara, Jalisco, 44329, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 2, 2021
First Posted
February 24, 2021
Study Start
January 1, 2021
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
October 2, 2023
Record last verified: 2023-09